The journal Science has chosen the HPTN 052 clinical trial, an international HIV prevention trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, as the 2011 Breakthrough of the Year. The study found that if HIV-infected heterosexual individuals begin taking antiretroviral medicines when their immune systems are relatively healthy as opposed to delaying therapy until the disease has advanced, they are 96 percent less likely to transmit the virus to their uninfected partners.
Quoted from HIV study named ‘2011 breakthrough of the year’ by Science on ScienceDaily: Top News
The study found that if HIV-infected heteroual individuals begin taking antiretroviral medicines when their immune systems are relatively healthy as opposed to delaying therapy until the disease has advanced, they are 96 percent less likely NIH/National Institute of Allergy and Infectious Diseases. (2011, December 25). HIV study named '2011 breakthrough of the year' by Science. ScienceDaily. Retrieved January 8, 2020 from 2011 Year NIH-funded treatment-as-prevention heralded as a major advance journal has chosen HPTN 052 clinical trial , an international prevention trial sponsored Tags: study, named, 2011, breakthrough, HIV - Stand der medizinischen - Stand der medizinischen Forschung. Seit der Entdeckung des Humanen Immundefizienz-Virus () Anfang der 1980er Jahre arbeitet die Forschung intensiv an der Entwicklung von Medikamenten zur Bekämpfung dieser lebensbedrohlichen Viruserkrankung. was slated to end in 2015, but an interim data review in May an independent data and safety monitoring board (DSMB) found that total 28 cases infection among